Selective androgen receptor modulators, usually shortened to SARMs, are a class of research compounds that bind to androgen receptors and are promoted online as a lower risk alternative to anabolic steroids for building muscle. No SARM is an approved drug for human use in the United States, and none of them are controlled substances that a standard workplace drug panel is built to detect. A typical 5, 10 or 12 panel urine, oral fluid or dip card screen used by employers is not designed to flag SARMs at all, which surprises people who assume any performance enhancing substance will show up on a routine test. This article explains what a workplace panel actually screens for, what kind of testing is actually capable of detecting SARMs, and where the health and marketing warnings on the subject come from.
What a standard workplace panel actually targets
Federal workplace drug testing programs, including the ones that apply to safety sensitive transportation employees, are built around a defined list of analytes, not an open ended search for any substance that might impair or enhance performance. The regulation that governs DOT covered testing, 49 CFR 40.85, lists marijuana metabolites, cocaine metabolites, amphetamines and methamphetamine, opioids, and phencyclidine as the analytes laboratories must test for. SARMs are not on that list, and neither are anabolic steroids. The same core analyte groups, sometimes expanded to 10 or 12 panels for non regulated workplace programs, are what most commercial dip cards and cups are built around, and the underlying federal structure for how those guidelines are set and updated is described in the Mandatory Guidelines for Federal Workplace Drug Testing Programs published in the Federal Register. None of these documents list a SARM compound as a target analyte for a standard immunoassay screen.
This means an employee who has used a SARM product will not trigger a positive result on a routine pre employment, random or post accident panel in the way that someone using an opioid or amphetamine would. The absence of a positive result on a standard panel says nothing about whether SARM use occurred. It only means the panel was never looking for it.
What it actually takes to detect a SARM
Detecting a SARM or its metabolites requires a dedicated, targeted laboratory method, almost always liquid chromatography tandem mass spectrometry (LC/MS or LC/MS/MS), run against a reference panel built specifically for anabolic and androgenic agents. This is a fundamentally different test than an immunoassay drug of abuse screen. Instead of an antibody reacting to a drug class, the laboratory looks for the exact mass and fragmentation pattern of a specific compound, such as ostarine, ligandrol or andarine, and compares it against a validated reference standard. Programs that run this kind of anabolic agent testing are typically sports governing bodies, military commands, and a limited number of employers with a specific policy reason to screen for performance enhancing substances, not general civilian workplace drug programs. A standard workplace vendor offering 5 to 12 panel cups or dip cards is not equipped to run this analysis, and it is not part of what DOT, SAMHSA or a typical non regulated employer panel is built to do.
Why SARMs are not an approved drug and what the FDA has said about the category
No SARM compound has been approved by the FDA as a safe and effective drug for any use, which means any SARM product sold for human consumption is being marketed outside the normal drug approval pathway. The FDA has specifically warned that many products marketed for bodybuilding, sold online and in retail stores and often labeled as dietary supplements, actually contain steroids or steroid like substances tied to serious and potentially life threatening health risks, including documented cases of liver injury. The agency has also pointed out that it does not review dietary supplements for safety and effectiveness before they reach the market, so a product labeled that way has not been vetted the way an approved drug has. That consumer guidance is laid out directly on the FDA's own site in Caution: Bodybuilding Products Can Be Risky. Employers and donors researching SARMs specifically should treat that warning as the baseline fact pattern: these are unapproved substances frequently sold under a supplement label, and the regulatory concern is about safety and lawful marketing, not about workplace drug test evasion.
This article is not the place to describe how to use, cycle or dose any SARM product, and American Screening Corporation does not provide that kind of guidance. Anyone with health questions about a product they have taken should talk to a licensed health care provider, not a drug testing vendor.
Workplace panel versus anabolic agent panel
| Substance class | Standard 5 to 12 panel workplace screen | Dedicated anabolic agent panel (LC/MS) | Confirmation method |
|---|---|---|---|
| Marijuana, cocaine, opiates, PCP, amphetamines | Yes, these are the core target analytes | Not applicable, different panel purpose | GC/MS or LC/MS/MS on any non negative screen |
| Prescription controlled substances (benzodiazepines, barbiturates, methadone and similar, where included) | Yes, on expanded 10 to 12 panel configurations | Not applicable | GC/MS or LC/MS/MS, reviewed by an MRO against prescription history |
| Anabolic steroids | No, not a target analyte on a standard immunoassay panel | Yes, this is the panel's purpose | LC/MS/MS against reference standards for specific steroid compounds |
| SARMs (ostarine, ligandrol, andarine and similar) | No, not a target analyte on a standard immunoassay panel | Yes, when the program specifically includes SARM reference compounds | LC/MS/MS against reference standards for the specific SARM compound |
The practical point for an employer reading this table is that a negative result on a standard workplace cup or dip card cannot be interpreted as proof that no SARM or steroid was used, and a positive result on one of these standard panels cannot be attributed to a SARM, because the panel was never built to react to one. Any program that has a specific reason to screen for anabolic agents, whether due to an athletic association rule, a military regulation, or an individual employer policy, needs to contract for the dedicated LC/MS anabolic agent service rather than assume an expanded standard panel covers it.
What happens when a result needs review
Every non negative result on a professionally run testing program, DOT regulated or not, should go through confirmation testing and then a review by a medical review officer (MRO), a licensed physician trained to interpret laboratory results and consider a donor's prescription and medical history before any result is reported as final. The federal regulation that establishes the MRO's role and the verification process for DOT covered testing is laid out in 49 CFR Part 40, Subpart G, and well run non regulated programs generally model their own review process on the same structure. For a program that specifically screens for anabolic agents, the same principle applies: a flagged result on a targeted LC/MS panel should still go through a documented review process before any employment or eligibility decision is made, and donors should have the opportunity to provide any relevant medical documentation.
Related reading on anabolic agent and sports testing
Employers building a program that needs to address performance enhancing substances, rather than only the standard drug of abuse analytes, may find it useful to read our articles on how anabolic steroid testing actually works and who tests for it and how sports organizations use drug testing to ensure fair play, both of which describe the same kind of targeted, non routine testing approach that applies to SARMs.
Frequently asked questions
Do SARMs show up on a standard workplace drug test?
No. SARMs are not target analytes on a standard 5, 10 or 12 panel immunoassay screen. Detecting a SARM requires a dedicated LC/MS anabolic agent panel that is built specifically to look for those compounds.
Are SARMs the same as anabolic steroids for testing purposes?
No. SARMs act on androgen receptors but are chemically distinct from anabolic steroids. Neither class is a target analyte on a standard workplace immunoassay panel, and both require a dedicated LC/MS anabolic agent panel for detection.
Has the approved by FDA any SARM product?
No SARM has been approved by the FDA as a safe and effective drug for human use. The FDA has warned that many bodybuilding products marketed as dietary supplements actually contain steroids or steroid like substances tied to serious health risks, including liver injury, and that dietary supplements are not reviewed for safety before they reach the market.
Who actually tests for SARMs?
Programs that specifically need to detect anabolic agents, such as sports governing bodies, military commands, or employers with a specific policy reason, contract for a dedicated LC/MS panel built around reference standards for those compounds. This is not part of a standard civilian workplace drug test panel.
What happens if a targeted anabolic agent test comes back non negative?
As with any drug testing program, a non negative result should go through confirmation testing and a documented review process, ideally modeled on the medical review officer structure used in DOT regulated testing, before any final decision is made.
Where can an employer source compliant workplace drug test supplies?
American Screening Corporation supplies drug test cups, dip cards and oral fluid tests for standard workplace programs, and distributors can review bulk options through the wholesale portal. Employers and distributors can also review retail options at the drug test cup collection.
This article is general information about drug testing science and procedure, not medical or legal advice. Employers should consult qualified counsel and a medical review officer for decisions about specific test results or program design.
